CVS Health’s efforts to dispense opioid overdose reversal drug naloxone without a prescription has already come to 23 states and the company has announced plans to expand to seven more over the course of the summer.
Forbes recently reported on CVS Health’s efforts to curb opioid abuse, highlighting its push to provide naloxone — the drug that reverses an opioid overdose — without a prescription through its pharmacies in 20 states by the end of the year, with plans to do so in all 50 states. The magazine spoke to CVS Health VP professional services Tom Davis about the efforts, and Davis notes that “when dispensing naloxone, our pharmacists counsel patients and caregivers on a number of important points including: identifying an overdose, the importance of calling 911, giving rescue breaths, administering naloxone and remaining with the patient until help arrives.” (Forbes)
The New York Times reports that the number of opioid prescriptions in the United States is falling for the first time since OxyContin hit the market in 1996. (New York Times)
A record number of Americans showed up last weekend to turn in their unused prescription drugs, according to the Drug Enforcement Agency.
The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 seeks to increase collaboration between health and enforcement bodies on drug abuse solutions.
Consumers looking for the most technologically advanced home pregnancy test available now have a new option from a leading brand.
Retailers and technology vendors convened at the fifth annual Health, Wellness and Technology Roundtable to discuss what they see in the current technology today, what they expect in 2016 and some of the unmet technology needs.
When implementation of Walgreens' naloxone program is complete, naloxone will be available without a prescription in more than 5,800 of Walgreens nearly 8,200 stores.